Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells.

British Journal of Pharmacology
A RoseA-A Weber

Abstract

Sorafenib is an inhibitor of several intracellular signalling kinases with anti-proliferative, anti-angiogenic and pro-apoptotic effects in tumour cells. Sorafenib is used in the therapy of advanced renal cell carcinoma, and several phase II clinical trials are being carried out in patients with urothelial carcinomas. Using a panel of human bladder cancer cell lines (RT4, T24, J82), we characterized systematically the effects of sorafenib on intracellular signalling, migration, proliferation and apoptosis. We demonstrated that at low concentrations (<1 microM), sorafenib is capable of significantly stimulating migration and proliferation of the bladder cancer cells. We hypothesize that these stimulatory effects on tumour cell functions might be explained by an activation of the Ras/ERK-1/2 signal transduction pathway. In addition, the comparison of different bladder cancer cell lines not only revealed a different biology (e.g. cell migration), but also a differential susceptibility to the anti-apoptotic effects of sorafenib. Finally, we confirmed in different bladder cancer cell lines the known inhibitory actions of sorafenib in pharmacological concentrations (> or =3 microM) on ERK-1/2 phosphorylation, migration and proliferat...Continue Reading

References

Jan 1, 1996·European Urology·D FontanaE Leonardo
Aug 26, 2000·Cancer Genetics and Cytogenetics·B PrzybojewskaP Jalmuzna
Jul 19, 2001·Journal of the National Cancer Institute·A A Adjei
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
May 23, 2002·European Journal of Cell Biology·Alexander HermannArtur-Aron Weber
Oct 9, 2002·Current Pharmaceutical Design·Scott Wilhelm, Du-Shieng Chien
Jul 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jose L Dominguez-EscrigBarry R Davies
Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans von der MaaseMichael Arning
Mar 7, 2006·The Journal of Urology·Guangbin XiaParkash S Gill
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
May 15, 2007·Oncogene·A S DhillonW Kolch
Jul 28, 2007·Pharmacotherapy·Cheryl A Grandinetti, Barry R Goldspiel
Jul 1, 2008·Der Urologe. Ausg. A·F Vom DorpH Rübben
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 5, 2008·The New England Journal of Medicine·Giancarlo Spinzi, Silvia Paggi
Apr 15, 2009·Anti-cancer Drugs·Paulo Cortes

❮ Previous
Next ❯

Citations

Nov 14, 2013·PloS One·Christian NiedworokJens W Fischer
Aug 2, 2014·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Marco Baron ToaldoFabio Piscaglia
Nov 12, 2014·International Journal of Molecular Sciences·Judith KnievelGünter Niegisch
Jun 23, 2015·Expert Opinion on Investigational Drugs·Clarisse R Mazzola, Joseph Chin
Jun 8, 2012·Cancer Biology & Therapy·M Danielle BarefordPaul Dent
May 9, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Benjamin D ZeitlinJacques E Nör
Jul 24, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maximilian A ArdeltJohanna Pachmayr
Aug 5, 2011·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis